About Chris
Chris defends pharmaceutical and medical device manufacturers in “bet the company” mass tort litigations. With extensive experience in managing large-scale litigation, Chris brings to the table an eye for streamlining workflows, improving efficiencies, and implementing cost-reduction measures. His work with discovery teams and vendors, in particular, has been recognized by clients and colleagues alike, making him a trusted advisor and leader in the legal community. The Legal 500 US recognized him as a key lawyer for Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices in 2024 and stated that he “is excellent at managing large-scale cases, where he has developed a particularly strong reputation for realizing efficiencies, including at the discovery phase.”
Chris defends pharmaceutical and medical device manufacturers in “bet the company” mass tort litigations. With extensive experience in managing large-scale litigation, Chris brings to the table an eye for streamlining workflows, improving efficiencies, and implementing cost-reduction measures. His work with discovery teams and vendors, in particular, has been recognized by clients and colleagues alike, making him a trusted advisor and leader in the legal community. The Legal 500 US recognized him as a key lawyer for Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices in 2024 and stated that he “is excellent at managing large-scale cases, where he has developed a particularly strong reputation for realizing efficiencies, including at the discovery phase.”
Chris defends pharmaceutical and medical device manufacturers in “bet the company” mass tort litigations. With extensive experience in managing large-scale litigation, Chris brings to the table an eye for streamlining workflows, improving efficiencies, and implementing cost-reduction measures. His work with discovery teams and vendors, in particular, has been recognized by clients and colleagues alike, making him a trusted advisor and leader in the legal community. The Legal 500 US recognized him as a key lawyer for Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices in 2024 and stated that he “is excellent at managing large-scale cases, where he has developed a particularly strong reputation for realizing efficiencies, including at the discovery phase.”
Chris defends pharmaceutical and medical device manufacturers in “bet the company” mass tort litigations. With extensive experience in managing large-scale litigation, Chris brings to the table an eye for streamlining workflows, improving efficiencies, and implementing cost-reduction measures. His work with discovery teams and vendors, in particular, has been recognized by clients and colleagues alike, making him a trusted advisor and leader in the legal community. The Legal 500 US recognized him as a key lawyer for Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices in 2024 and stated that he “is excellent at managing large-scale cases, where he has developed a particularly strong reputation for realizing efficiencies, including at the discovery phase.”
Chris defends pharmaceutical and medical device manufacturers in “bet the company” mass tort litigations. With extensive experience in managing large-scale litigation, Chris brings to the table an eye for streamlining workflows, improving efficiencies, and implementing cost-reduction measures. His work with discovery teams and vendors, in particular, has been recognized by clients and colleagues alike, making him a trusted advisor and leader in the legal community. The Legal 500 US recognized him as a key lawyer for Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices in 2024 and stated that he “is excellent at managing large-scale cases, where he has developed a particularly strong reputation for realizing efficiencies, including at the discovery phase.”
